Vote Scores
Filings read through

How funds voted at Kobayashi Pharmaceutical Co., Ltd.

Filers reporting
31, year to 30 June 2026
Latest meeting on file
Meetings on file
4

In the year to 30 June 2026, 31 filers on Form N-PX reported votes at Kobayashi Pharmaceutical Co., Ltd.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 210 marks to the ballot items, each with or against management. 78.6% of the marks are with management.

In the year to 30 June 2026, no say-on-pay item is on file for Kobayashi Pharmaceutical Co., Ltd.. So there is no figure to give.

By filers reporting in the year to 30 June 2026, Kobayashi Pharmaceutical Co., Ltd. was number 6,849 of 11,972 companies with a page and votes in that year. The number of filers reporting at Kobayashi Pharmaceutical Co., Ltd. fell by 3.1% from the year to 30 June 2025 to the year to 30 June 2026. At the companies on this site with filers in both years, the total of filers reporting rose by 6.0%. In all seasons on file, category DIRECTOR ELECTIONS is 75.0% of the vote records at Kobayashi Pharmaceutical Co., Ltd.. At all companies on this site, it is 52.2%.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 27 Mar 2026

31 filers reported votes at this meeting in the year to 30 June 2026. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    11 nominees. 91.7% of the reported votes are for. 16 filers withheld from or voted against at least one nominee.

    519 vote records from 31 filers. 0 of the 30 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 15 fund families
    • For 15
  2. Item 2: Director elections (nominees put forward by security holders)

    1 nominee. 0.0% of the reported votes are for. 2 filers withheld from or voted against at least one nominee.

    5 vote records from 3 filers. 0 of the 2 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of one fund family
    • Abstain or withhold 1
  3. Item 3: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    96 vote records from 31 filers. 0 of the 30 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 15 fund families
    • For 15
  4. Item 4: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    57 vote records from 31 filers. 0 of the 30 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 15 fund families
    • For 15
  5. Item 5: Amend Articles to Add Provision on Product Quality Control and Safety

    48 vote records from 31 filers. 2 of the 30 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 15 fund families
    • For 1
    • Against 14
    • Against management 1
  6. Item 6: Shareholder Proposal Regarding Outside Board Chair

    48 vote records from 31 filers. 15 of the 30 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 15 fund families
    • For 9
    • Against 6
    • Against management 9
  7. Item 7: Amend Articles to Provide Monthly Reports to Outside Directors

    48 vote records from 31 filers. 2 of the 30 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 15 fund families
    • For 1
    • Against 14
    • Against management 1
  8. Item 8: Shareholder proposal: CORPORATE GOVERNANCE

    43 vote records from 28 filers. 26 of the 28 filers that marked the item voted against management.

    • Positions of 14 fund families
    • Against 1
    • Abstain or withhold 13
    • Against management 13

Positions of the fund families at the meeting of 27 Mar 2026

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

  • Proposal A: Amend Articles to Add Provision on Product Quality Control and Safety
  • Proposal B: Shareholder Proposal Regarding Outside Board Chair
  • Proposal C: Amend Articles to Provide Monthly Reports to Outside Directors
  • Proposal D: Shareholder proposal: CORPORATE GOVERNANCE

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Kobayashi Pharmaceutical Co., Ltd., meeting of 27 Mar 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familyProposal AProposal BProposal CProposal D
BlackRock and iSharesAgainstAgainstAgainstAgainst
BNY MellonAgainstFor, against managementAgainstAbstain, against management
Charles SchwabFor, against managementFor, against managementFor, against managementNo report
EquitableAgainstFor, against managementAgainstAbstain, against management
FidelityAgainstAgainstAgainstAbstain, against management
Franklin TempletonAgainstFor, against managementAgainstAbstain, against management
Goldman SachsAgainstFor, against managementAgainstAbstain, against management
InvescoAgainstFor, against managementAgainstAbstain, against management
MFSAgainstFor, against managementAgainstAbstain, against management
Morgan Stanley, Eaton Vance and CalvertAgainstFor, against managementAgainstAbstain, against management
Northern Trust and FlexSharesAgainstAgainstAgainstAbstain, against management
Nuveen and TIAAAgainstAgainstAgainstAbstain, against management
PIMCOAgainstFor, against managementAgainstAbstain, against management
State Street and SPDRAgainstAgainstAgainstAbstain, against management
VanguardAgainstAgainstAgainstAbstain, against management

Every meeting on file

Meetings of Kobayashi Pharmaceutical Co., Ltd., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2026318not reported
year to 30 June 2025323not reported
year to 30 June 2025324not reported
year to 30 June 2024534not reported

Say-on-pay, season by season

Say-on-pay at Kobayashi Pharmaceutical Co., Ltd.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202631not reportednot reported
year to 30 June 202532not reportednot reported
year to 30 June 202453not reportednot reported
Kobayashi Pharmaceutical Co., Ltd. and the median of companies on this site, year to 30 June 2026
Say-on-payThis companyMedian of companies on this site
Filers against managementnot reported6.6%
Reported shares against managementnot reported2.9%

The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Kobayashi Pharmaceutical Co., Ltd. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS1,71075.0%
AUDIT-RELATED30.1%
COMPENSATION1968.6%
CORPORATE GOVERNANCE36716.1%
OTHER40.2%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at Kobayashi Pharmaceutical Co., Ltd.. https://votescores.com/company/kobayashi-pharmaceutical-co-ltd/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Kobayashi Pharmaceutical Co., Ltd. are on file?
4 meetings are on file, from 28 Mar 2024 to 27 Mar 2026. 4 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at Kobayashi Pharmaceutical Co., Ltd.?
Filers reported 4 proposals from security holders that the site could tell apart in the year to 30 June 2026. They fall in 1 meeting. The ballot on this page shows each proposal.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Kobayashi Pharmaceutical Co., Ltd. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Kobayashi Pharmaceutical Co., Ltd., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .